journal
https://read.qxmd.com/read/37865827/primary-central-nervous-system-vasculitis-and-headache-ten-themes
#61
REVIEW
David S Younger
PURPOSE OF REVIEW: The primary central nervous system (CNS) vasculitides refers to clinicopathologic disorders that share the histopathology of inflammation of cerebral or spinal blood vessels. Unrecognized and therefore untreated, vasculitis of the CNS results in irreversible injury and disability making these disorders of paramount importance to clinicians. RECENT FINDINGS: Headache is an important clue to vasculitic involvement of CNS vessels. CNS vasculitis can be primary, in which only intracranial or spinal vessels are involved in the inflammatory process, or secondary to another known disorder with overlapping systemic involvement...
December 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37889571/electrical-stimulation-of-the-peripheral-and-central-vestibular-system
#62
JOURNAL ARTICLE
Christophe Lopez, Kathleen E Cullen
PURPOSE OF REVIEW: Electrical stimulation of the peripheral and central vestibular system using noninvasive (galvanic vestibular stimulation, GVS) or invasive (intracranial electrical brain stimulation, iEBS) approaches have a long history of use in studying self-motion perception and balance control. The aim of this review is to summarize recent electrophysiological studies of the effects of GVS, and functional mapping of the central vestibular system using iEBS in awake patients. RECENT FINDINGS: The use of GVS has become increasingly common in the assessment and treatment of a wide range of clinical disorders including vestibulopathy and Parkinson's disease...
October 26, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37865841/covid-19-related-headaches-epidemiology-pathophysiology-impacts-and-management
#63
JOURNAL ARTICLE
Olalekan Lee Aiyegbusi
PURPOSE OF REVIEW: This is an expert overview of the recent literature on the nature, epidemiology, pathophysiology, impact, and management of COVID-19 related headache, in the acute phase of infection and in post-COVID-19 syndrome. RECENT FINDINGS: Headache is one of the commonest symptoms of COVID-19 during acute infection and it is often experienced by individuals who go on to develop long COVID. There is a higher prevalence of headache in individuals with long COVID who contracted the Delta variant than in those who were infected with the Wuhan or Alpha variants...
October 4, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37865833/remote-ischemic-conditioning-as-an-emerging-tool-to-improve-corticospinal-transmission-in-individuals-with-chronic-spinal-cord-injury
#64
JOURNAL ARTICLE
Yu-Kuang Wu, Jill M Wecht, Ona E Bloom, Gino S Panza, Noam Y Harel
PURPOSE OF REVIEW: Remote ischemic conditioning (RIC) involves transient blood flow restriction to one limb leading to systemic tissue-protective effects. RIC shares some potential underlying mechanisms with intermittent hypoxia (IH), in which brief bouts of systemic hypoxia trigger increases in growth factor expression and neural plasticity. RIC has shown promise in acute myocardial infarction and stroke but may be applicable toward chronic neuropathology as well. Consequently, this review discusses similarities and differences between RIC and IH and presents preliminary and ongoing research findings regarding RIC...
October 2, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37678340/degenerative-and-cognitive-diseases
#65
JOURNAL ARTICLE
Rosie E Curiel Cid
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37678339/therapeutic-developments-for-valosin-containing-protein-mediated-multisystem-proteinopathy
#66
REVIEW
Victoria Boock, Bhaskar Roy, Gerald Pfeffer, Virginia Kimonis
PURPOSE OF REVIEW: Missense mutations in valosin-containing protein (VCP) can lead to a multisystem proteinopathy 1 (MSP1) with any combination of limb-girdle distribution inclusion body myopathy (IBM) (present in about 90% of cases), Paget's disease of bone, and frontotemporal dementia (IBMPFD). VCP mutations lead to gain of function activity with widespread disarray in cellular function, with enhanced ATPase activity, increased binding with its cofactors, and reduced mitofusin levels...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37678338/editorial-framing-artificial-intelligence-to-neuromuscular-disorders
#67
JOURNAL ARTICLE
Benedikt Schoser
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37678337/current-drug-treatment-of-myasthenia-gravis
#68
REVIEW
Fiammetta Vanoli, Renato Mantegazza
PURPOSE OF REVIEW: Myasthenia Gravis (MG) is a rare neurological disorder affecting the neuromuscular junction. Clinical hallmarks are fatigability and weakness affecting the extraocular, axial, limb and/or respiratory muscles. Despite immunosuppressive treatment, mainly based on corticosteroids and nonsteroidal immunosuppressants, the burden of MG is still significant, both in terms of inadequate disease control and burdensome side effects. Driven by such limits, the past years have been characterized by an escalation of MG drug development, with novel molecules which now focuses on having a more targeted effect, with a higher safety and efficacy profile...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37678336/editorial-neuromuscular-diseases-differential-diagnosis-and-targeted-treatment
#69
EDITORIAL
Claudia Sommer
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639489/immune-checkpoint-inhibitors-induced-side-effects-of-the-peripheral-nervous-system
#70
REVIEW
Thomas Hundsberger, Bettina Schreiner, Patrick Roth
PURPOSE OF REVIEW: This review highlights recent knowledge on the diagnosis and treatment of immune checkpoint inhibitor-induced neurological side effects (irNAE) focussing on the neuromuscular system. RECENT FINDINGS: irNAEs mainly resemble sporadic neuromuscular autoimmune diseases and paraneoplastic neurological syndromes. However, neurological symptoms may be unspecific (muscle weakness, fatigue) in the oncological setting and carry the risk of misdiagnosis and delayed therapeutic intervention...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639488/management-of-neuropsychiatric-symptoms-in-dementia
#71
REVIEW
D P Devanand
PURPOSE OF REVIEW: The purpose is to review the results and clinical implications of recent studies of neuropathology in relation to neuropsychiatric symptoms (NPS) in Alzheimer's disease and related dementias, and discuss new therapeutic approaches based on evidence from clinical trials. RECENT FINDINGS: In a large autopsy series from a national consortium, multiple neuropathologies of dementia subtypes were common and increased severity of specific NPS during life was associated with greater severity of neuropathology across diagnoses...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639480/the-current-clinical-perception-of-myotonic-dystrophy-type-2
#72
REVIEW
Felix Kleefeld, Benedikt Schoser
PURPOSE OF REVIEW: Myotonic dystrophy type 2 (DM2) is a genetic disorder belonging to the spectrum of myotonic dystrophies. DM2 is characterized by progressive muscle weakness, wasting and muscle pain (myalgia), but can also affect many other organ systems. In this review, we provide an updated overview on the research literature on DM2 with a focus on the management of multisystemic involvement and atypical clinical phenotypes. RECENT FINDINGS: Recent studies have focused on different aspects of multisystemic involvement...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639472/toxic-neuropathies
#73
REVIEW
Alexander M Rossor, Hadi Manji
PURPOSE OF REVIEW: Immunotherapy has had a significant impact on the treatment of an increasing number of cancers as well as in inflammatory, rheumatological and gastroenterological conditions.Recreational nitrous oxide use is now a global epidemic. Linezolid is now recommended for the treatment of drug-resistant tuberculosis (TB); neuropathy is a significant cause of morbidity.Global warming will result in increasing toxin exposure, such as ciguatera, in previously unaffected areas. RECENT FINDINGS: With increasing experience, the pathophysiology underlying the neuropathic complications of these drugs has become clear with guidelines now available, for the complications of immune check-point inhibitors and nitrous oxide toxicity...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639464/pan-neurofascin-autoimmune-nodopathy-a-life-threatening-but-reversible-neuropathy
#74
REVIEW
Luise Appeltshauser, Kathrin Doppler
PURPOSE OF REVIEW: Autoimmune nodopathies are immune-mediated neuropathies associated with antibodies targeting the peripheral node of Ranvier. Recently, antibodies against all neurofascin-isoforms (pan-neurofascin) have been linked to a clinical phenotype distinct from previously described autoimmune nodopathies. Here, we aim at highlighting the molecular background and the red flags for diagnostic assessment and provide treatment and surveillance approaches for this new disease. RECENT FINDINGS: Neurofascin-isoforms are located at different compartments of the node of Ranvier: Neurofascin-186 at the axonal nodal gap, and Neurofascin-155 at the terminal Schwann cell loops at the paranode...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639461/advanced-brain-imaging-for-the-diagnosis-of-alzheimer-disease
#75
REVIEW
Yi-Ting Tina Wang, Pedro Rosa-Neto, Serge Gauthier
PURPOSE OF REVIEW: The purpose is to review the latest advances of brain imaging for the diagnosis of Alzheimer disease (AD). RECENT FINDINGS: Brain imaging techniques provide valuable and complementary information to support the diagnosis of Alzheimer disease in clinical and research settings. The recent FDA accelerated approvals of aducanumab, lecanemab and donanemab made amyloid-PET critical in helping determine the optimal window for anti-amyloid therapeutic interventions...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639450/thymectomy-in-myasthenia-gravis
#76
REVIEW
Jakob Rath, Bernhard Moser, Fritz Zimprich
PURPOSE OF REVIEW: Thymectomy has long been used in the treatment of patients with myasthenia gravis and antibodies against the acetylcholine receptor. However, its effectiveness has only been proven a few years ago in a randomized controlled trial in patients under the age of 65. Here, we review the current literature focusing on patient subgroups, potential biomarkers for outcome prediction and the choice of surgical approach. RECENT FINDINGS: Long-term follow-up studies after thymectomy confirmed that the benefits regarding clinical outcome parameters and a reduced need for immunosuppressive treatment persist...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639448/a-patient-with-neuropathy-and-ataxia-what-do-i-have-to-consider
#77
REVIEW
Leslie J Roberts, David J Szmulewicz
PURPOSE OF REVIEW: An increasing number of peripheral neuro(no)pathies are identified as involving other components of the neurological system, particularly those that further impair balance. Here we aim to outline an evidence-based approach to the diagnosis of patients who present with a somatosensory disorder which also involves at least one other area of neurological impairment such as the vestibular, auditory, or cerebellar systems. RECENT FINDINGS: Detailed objective investigation of patients who present with sensory impairment, particularly where the degree of imbalance is greater than would be expected, aids the accurate diagnosis of genetic, autoimmune, metabolic, and toxic neurological disease...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639435/vitamins-in-neuropathy-pathophysiological-and-therapeutic-roles
#78
REVIEW
Peng Chen, Xue-Jun Song
PURPOSE OF REVIEW: Vitamin deficiency is a risk factor in the development of peripheral neuropathy, which leads to complex and severe diseases. This review provides an update overview of the literature on the roles of vitamins in peripheral neuropathy, highlighting their pathophysiological and therapeutic roles. RECENT FINDINGS: The importance and clinical manifestations and implications of the vitamins and vitamin deficiencies are further demonstrated in peripheral neuropathy and the associated diseases...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37639402/current-avenues-of-gene-therapy-in-pompe-disease
#79
REVIEW
Carmen Leon-Astudillo, Prasad D Trivedi, Ramon C Sun, Matthew S Gentry, David D Fuller, Barry J Byrne, Manuela Corti
PURPOSE OF REVIEW: Pompe disease is a rare, inherited, devastating condition that causes progressive weakness, cardiomyopathy and neuromotor disease due to the accumulation of glycogen in striated and smooth muscle, as well as neurons. While enzyme replacement therapy has dramatically changed the outcome of patients with the disease, this strategy has several limitations. Gene therapy in Pompe disease constitutes an attractive approach due to the multisystem aspects of the disease and need to address the central nervous system manifestations...
October 1, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37591308/an-update-on-becker-muscular-dystrophy
#80
REVIEW
Volker Straub, Michela Guglieri
PURPOSE OF REVIEW: The purpose of this review is to summarise the recent developments in trial readiness, natural history studies, and interventional clinical trials for Becker muscular dystrophy (BMD). RECENT FINDINGS: As several treatment concepts have claimed to convert patients with Duchenne muscular dystrophy (DMD) into a BMD phenotype, BMD itself has moved into the focus of clinical research. Natural history studies have helped to better characterize patients with BMD and the disease is now a target for interventional trials...
October 1, 2023: Current Opinion in Neurology
journal
journal
20092
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.